MicroRNA signatures discriminate between uterine and ovarian serous carcinomas.


Synchronous endometrial and ovarian malignancies occur in 5% of women presenting with endometrial cancer and 10% of patients presenting with ovarian malignancy. When a high-grade serous carcinoma concurrently involves both ovary and endometrium, pathological determination of whether they are synchronous primaries or metastatic tumors from one primary site… (More)
DOI: 10.1016/j.humpath.2018.02.019


  • Presentations referencing similar topics